Last updated: 2026-09-09 08:41:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Clene Inc. (CLNN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3.65, with a market capitalization of $49.47M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.60 to $13.50. This page covers its latest market performance, valuation, price trends and company information.
$49.47M | |
$3.78 | |
$356.40 | |
$2.28 | |
$3.62 | |
16.00 | |
83.03K | |
-- | |
$13.50 | |
$3.60 | |
-- | |
-- |
Clene Inc. (CLNN) is trading at $3.65 in pre-market trading as of 2026-09-09 08:24:00, up 0.75% ($0.03) from the previous close of $3.62
Pre-market trading shows how investors are pricing CLNN before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Clene Inc. (CLNN) moved from $4.23 to $3.65, representing a decline of 13.78% ($0.58).
The stock traded between $3.60 and $4.74 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 126.92 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0.5%
CLNN is currently trading at $3.65, placing it 0.5% of the way from its 52-week low of $3.60 to its 52-week high of $13.50. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 79 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Clene Inc. (CLNN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.